Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

PF-06823859 is a potent, selective, humanised immunoglobulin 1-neutralising monoclonal antibody (mAb) directed against human ...

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...